Urologix, Inc.
ULGX · OTC
6/30/2014 | 6/30/2013 | 6/30/2012 | 6/30/2011 | |
|---|---|---|---|---|
| Market Cap | $3,713 | $7,453 | $11,351 | $13,828 |
| - Cash | $718 | $2,290 | $1,899 | $3,061 |
| + Debt | $5,333 | $5,333 | $0 | $0 |
| Enterprise Value | $8,328 | $10,496 | $9,452 | $10,767 |
| Revenue | $14,235 | $16,590 | $17,027 | $12,571 |
| % Growth | -14.2% | -2.6% | 35.4% | – |
| Gross Profit | $6,093 | $8,183 | $8,382 | $6,541 |
| % Margin | 42.8% | 49.3% | 49.2% | 52% |
| EBITDA | -$6,344 | -$3,048 | -$3,463 | -$3,160 |
| % Margin | -44.6% | -18.4% | -20.3% | -25.1% |
| Net Income | -$7,608 | -$4,292 | -$4,695 | -$3,733 |
| % Margin | -53.4% | -25.9% | -27.6% | -29.7% |
| EPS Diluted | -0.36 | -0.21 | -0.32 | -0.26 |
| % Growth | -71.4% | 34.4% | -23.1% | – |
| Operating Cash Flow | -$1,530 | -$1,959 | -$713 | -$2,370 |
| Capital Expenditures | -$42 | -$79 | -$57 | -$272 |
| Free Cash Flow | -$1,572 | -$2,038 | -$770 | -$2,642 |